FDA Approved: APREPITANT — Original Application (Sandoz Inc)

View source ↗

Summary

The FDA approved Sandoz Inc's original ANDA for aprepitant, a generic NK1 receptor antagonist, for the prevention of chemotherapy-induced nausea and vomiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Postoperative Nausea and Vomiting

Drugs mentioned

• Aprepitant (aprepitant)

Snippet

ORIG AP for APREPITANT (APREPITANT)